Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Share-based Payment Arrangement, Expense, Tax Benefit

1.9 / 5 stars · 34/88 Roast Me

AKEBIA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense, Tax Benefit

AKEBIA THERAPEUTICS, INC. (AKBA) reported Share-based Payment Arrangement, Expense, Tax Benefit of $900.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-14.

Discontinued › Expense Statement › Income Tax

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2016-03-14

  • AKEBIA THERAPEUTICS, INC. share-based payment arrangement, expense, tax benefit for fiscal 2015 was $900.00K, a 0.00% change from fiscal 2014.
  • AKEBIA THERAPEUTICS, INC. share-based payment arrangement, expense, tax benefit for fiscal 2014 was $900.00K.
Period endShare-based Payment Arrangement, Expense, Tax Benefit 12 month
2015-12-31$900.00K
10-K · filed 2016-03-14
2014-12-31$900.00K
10-K · filed 2016-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33